Research Projects
Dr. Kumar is the director of the Julius L. Chambers Biomedical/Biotechnology Research Institute (BBRI) at North Carolina Central University.
Topics:
Research Priority:
Asialo-rhuEPO, a non-hematopoietic recombinant human erythropoietin (EPO) derivative lacking sialic acid, has been reported to display broad tissue-protective effects against damage triggered by is
Research Priority:
The objective of this project is to increase the number of students getting tested to identify persons who may be at increased risk of becoming infected with HIV, or if already infected, to prevent
Topics:
Research Priority:
The transportation infrastructure is on the cusp of a major shift from predesigned controls and patterning to dynamic AI-driven and IOT communication.
Topics:
Research Priority:
Kaposi’s sarcoma herpesvirus (KSHV/HHV8) is a human oncogenic virus and, like all herpesviruses, establishes a lifelong infection in the host.
Topics:
Research Priority:
This project is an application for the continuation of a cooperative agreement (U54), “Mechanisms of Alcoholic Pathology” (MAP), between faculties of the Biomedical/Biotechnology Research Institute
Research Priority:
Over 250,000 new cases of invasive breast cancer are expected to be diagnosed in the United States each year.
Topics:
Research Priority:
Neisseria gonorrhea infection induces inflammatory responses that are responsible for the symptoms of gonococcal diseases. The
Topics:
Research Priority:
This proposal is a request for funds for the development of a unique instrument for the study of coherent elastic neutrino-nucleus scattering (CEvNS) on germanium.
Research Priority:
The proposed project is to conduct research in coherent elastic neutrino-nucleus scattering (CEvNS) and formalize participation in the COHERENT collaboration for the principal investigator (PI).